San Bruno, CA, United States of America

Devan Naduthambi

This inventor holds 36 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 16 EPO patents, primarily in Cancer Therapeutics. Top assignee: Gilead Sciences, Inc.. Active years: 2017-2026.

USPTO Granted Patents = 36 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 11.4

ph-index = 5

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 2017-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
PD-1 Inhibitors
MCL-1 Inhibitors
Phospholipid Compounds
SARS-COV2 Protease Inhibitors
Tank-Binding Kinase
Phosphatidylinositol 3-Kinase
Substituted Pyridotriazines
Prodrugs
Nucleotide Analogues
36 patents (USPTO):Explore Patents

Title: The Innovative Journey of Devan Naduthambi

Introduction: Devan Naduthambi, a talented inventor based in San Bruno, CA, has made significant contributions to the field of technology through his creative and groundbreaking inventions.

Latest Patents: Devan Naduthambi holds several patents in various technological domains, showcasing his versatility and ingenuity in the innovation landscape.

Career Highlights: With a passion for pushing the boundaries of technology, Devan Naduthambi has had a successful career marked by numerous groundbreaking inventions that have revolutionized the industry.

Collaborations: Throughout his career, Devan Naduthambi has collaborated with leading tech companies, research institutions, and universities to further enhance his innovative ideas and bring them to life.

Conclusion: Devan Naduthambi's dedication to innovation and his remarkable contributions to the technological field make him a standout inventor whose work continues to inspire and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…